Endi Wang
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 40
- Oncology 30
- Viral-associated cancers and disorders 23
- Co-authors
- Charles Blake Hutchinson (8 shared papers)Gino Cortopassi (2 shared papers)Siby Sebastian (15 shared papers)Qin Huang (8 shared papers)Catherine Rehder (15 shared papers)Alice Wong (1 shared paper)Imran Siddiqi (12 shared papers)James L. Rubenstein (2 shared papers)
- Journals
- American Journal of Clinical Pathology (15 papers)Archives of Pathology & Laboratory Medicine (14 papers)Medicine (9 papers)Human Pathology (7 papers)American Journal of Dermatopathology (6 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Endi Wang
119 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 89
- Pathology and Forensic Medicine 704
- Genetics 415
- Hematology 338
- Neurology 329
- Oncology 511
Countries citing papers authored by Endi Wang
This map shows the geographic impact of Endi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Endi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Endi Wang more than expected).
Fields of papers citing papers by Endi Wang
This network shows the impact of papers produced by Endi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Endi Wang. The network helps show where Endi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Endi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 266 | |
| 2 | 2010 | 148 | |
| 3 | 2004 | 145 | |
| 4 | 1995 | 107 | |
| 5 | 2009 | 73 | |
| 6 | 1997 | 71 | |
| 7 | 2010 | 68 | |
| 8 | 2015 | 56 | |
| 9 | 2016 | 50 | |
| 10 | 2012 | 46 | |
| 11 | 2011 | 46 | |
| 12 | 2014 | 43 | |
| 13 | 2014 | 43 | |
| 14 | 2011 | 42 | |
| 15 | 2012 | 37 | |
| 16 | 2012 | 35 | |
| 17 | 2021 | 34 | |
| 18 | 2009 | 32 | |
| 19 | 2013 | 31 | |
| 20 | 2011 | 31 |
About Endi Wang
Endi Wang is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Hematology and Molecular Biology, having authored 129 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (40 papers), Viral-associated cancers and disorders (23 papers), Chronic Lymphocytic Leukemia Research (20 papers), Acute Myeloid Leukemia Research (15 papers), Cutaneous lymphoproliferative disorders research (12 papers), CNS Lymphoma Diagnosis and Treatment (11 papers), Histiocytic Disorders and Treatments (9 papers) and Multiple Myeloma Research and Treatments (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (704 citations), Genetics (415 citations), Hematology (338 citations), Neurology (329 citations) and Oncology (511 citations). Endi Wang has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Charles Blake Hutchinson, Gino Cortopassi, Siby Sebastian, Qin Huang, Catherine Rehder, Alice Wong, Imran Siddiqi, James L. Rubenstein, Jon Karch and Marc Shuman. Their work appears in journals such as American Journal of Clinical Pathology, Archives of Pathology & Laboratory Medicine, Medicine, Human Pathology and American Journal of Dermatopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.